Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manabu Muto

Showing results (241-250 of 351) with videos related to

Pageof 36
Sort By:
International Journal of Clinical Oncology|November 11, 2016
Association between UGT1A1*28*28 genotype and lung cancer in the Japanese populationYoshitaka Nishikawa, Masashi Kanai, Maiko Narahara, et al.
Clinical Kidney Journal|February 17, 2025
Cancer diagnosis and prognosis after initiation of hemodialysis: multicenter Japan CANcer and DialYsis (J-CANDY) studyNaoya Toriu, Shinya Yamamoto, Takeshi Matsubara, et al.
Japanese Journal of Clinical Oncology|November 4, 2020
A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinomaChikatoshi Katada, Mitsuhiro Sugawara, Hiroki Hara, et al.
Scientific Reports|September 17, 2015
Protective role of ALDH2 against acetaldehyde-derived DNA damage in oesophageal squamous epitheliumYusuke Amanuma, Shinya Ohashi, Yoshiro Itatani, et al.
Gastrointestinal Endoscopy|June 28, 2011
Long-term outcome of transoral organ-preserving pharyngeal endoscopic resection for superficial pharyngeal cancerManabu Muto, Hironaga Satake, Tomonori Yano, et al.
International Journal of Clinical Oncology|May 1, 2025
Personalized prognostic model for colorectal cancer in the era of precision medicine: a dynamic approach based on real-world dataKeisuke Okura, Keita Fukuyama, Satoru Seo, et al.
Cancer Science|December 18, 2016
SIX1 maintains tumor basal cells via transforming growth factor-β pathway and associates with poor prognosis in esophageal cancerTakao Nishimura, Masashi Tamaoki, Rie Komatsuzaki, et al.
Journal of Pharmaceutical Health Care and Sciences|August 27, 2024
Subjective symptoms are triggers for the detection of immune checkpoint inhibitor-induced interstitial lung disease and associate with disease severity: a single-center retrospective studyMari Yokoi, Atsushi Yonezawa, Daiki Hira, et al.
Scientific Reports|April 25, 2018
RUNX1 positively regulates the ErbB2/HER2 signaling pathway through modulating SOS1 expression in gastric cancer cellsYoshihide Mitsuda, Ken Morita, Gengo Kashiwazaki, et al.
Cancer Medicine|March 13, 2026
Clinical Implications of Nutritional Intake in Patients With Esophageal Squamous Cell Carcinoma Receiving Chemoradiotherapy and Neoadjuvant ChemotherapyYumiko Tamai, Atsushi Yamada, Chikatoshi Katada, et al.
Pageof 36

Showing results (241-250 of 351) with videos related to

Sort By:
Pageof 36
International Journal of Clinical Oncology|November 11, 2016
Association between UGT1A1*28*28 genotype and lung cancer in the Japanese populationYoshitaka Nishikawa, Masashi Kanai, Maiko Narahara, et al.
Clinical Kidney Journal|February 17, 2025
Cancer diagnosis and prognosis after initiation of hemodialysis: multicenter Japan CANcer and DialYsis (J-CANDY) studyNaoya Toriu, Shinya Yamamoto, Takeshi Matsubara, et al.
Japanese Journal of Clinical Oncology|November 4, 2020
A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinomaChikatoshi Katada, Mitsuhiro Sugawara, Hiroki Hara, et al.
Scientific Reports|September 17, 2015
Protective role of ALDH2 against acetaldehyde-derived DNA damage in oesophageal squamous epitheliumYusuke Amanuma, Shinya Ohashi, Yoshiro Itatani, et al.
Gastrointestinal Endoscopy|June 28, 2011
Long-term outcome of transoral organ-preserving pharyngeal endoscopic resection for superficial pharyngeal cancerManabu Muto, Hironaga Satake, Tomonori Yano, et al.
International Journal of Clinical Oncology|May 1, 2025
Personalized prognostic model for colorectal cancer in the era of precision medicine: a dynamic approach based on real-world dataKeisuke Okura, Keita Fukuyama, Satoru Seo, et al.
Cancer Science|December 18, 2016
SIX1 maintains tumor basal cells via transforming growth factor-β pathway and associates with poor prognosis in esophageal cancerTakao Nishimura, Masashi Tamaoki, Rie Komatsuzaki, et al.
Journal of Pharmaceutical Health Care and Sciences|August 27, 2024
Subjective symptoms are triggers for the detection of immune checkpoint inhibitor-induced interstitial lung disease and associate with disease severity: a single-center retrospective studyMari Yokoi, Atsushi Yonezawa, Daiki Hira, et al.
Scientific Reports|April 25, 2018
RUNX1 positively regulates the ErbB2/HER2 signaling pathway through modulating SOS1 expression in gastric cancer cellsYoshihide Mitsuda, Ken Morita, Gengo Kashiwazaki, et al.
Cancer Medicine|March 13, 2026
Clinical Implications of Nutritional Intake in Patients With Esophageal Squamous Cell Carcinoma Receiving Chemoradiotherapy and Neoadjuvant ChemotherapyYumiko Tamai, Atsushi Yamada, Chikatoshi Katada, et al.
Pageof 36